Skip to content
Toggle Navigation
Home
About
Services
Regulatory Affairs Services
Pharmacovigilance Services
Quality Compliance
Blog
Search for:
English
عربي
(
Arabic
)
Deutsch
(
German
)
简体中文
(
Chinese (Simplified)
)
Français
(
French
)
Italiano
(
Italian
)
日本語
(
Japanese
)
한국어
(
Korean
)
Español
(
Spanish
)
Contact Us
Regulatory Affairs
Home
Regulatory Affairs
Posts in Category: Regulatory Affairs
Biosimilars Registration: SFDA Considerations
Published On: 16/03/2025
By
Regulatory Editor
Veterinary Drug Registration in SFDA
Published On: 08/02/2025
By
Abeer Mazyad
How to write Economic Evaluation Studies (EES) for SFDA?
Published On: 14/01/2025
By
Madiha Baaj
SaMD Registration in SFDA (Software as a Medical Device)
Published On: 07/12/2024
By
Yumna Siraj
MDMA Update and Change of Information
Published On: 06/12/2024
By
Mohamed Bashim
Overview of SFDA Conditional Approval for New Medicines
Published On: 02/12/2024
By
Madiha Baaj
SFDA Drug Pricing Rules in Saudi Arabia
Published On: 30/11/2024
By
Rawd Alsubaie
CAR T Cell Registration in SFDA
Published On: 08/07/2024
By
Regulatory Editor
Scientific Office Requirements by SFDA
Published On: 01/03/2024
By
Regulatory Editor
Reporting Medical Device Incidents & Adverse Events to SFDA
Published On: 23/02/2024
By
Heba Rasheed
Breakthrough Medicines Designation in SFDA
Published On: 12/02/2024
By
Madiha Baaj
How to implement PMCF in Saudi Arabia
Published On: 09/02/2024
By
Heba Rasheed
1
2
3
4
Next
Page load link
Go to Top